Multiple Sclerosis
Conference Coverage
A better MS measure?
A ‘digital carpet’ may provide more granular information about functional decline in patients with MS.
Conference Coverage
Cutting calories may benefit cognition in MS
For patients with MS, cognition can be positively influenced by healthy dietary habits.
Conference Coverage
High level of psychiatric morbidity in prodromal MS
The relative risk of psychiatric morbidity was up to 88% higher in patients with MS, compared with their counterparts without the disease.
Conference Coverage
MOGAD: Immunotherapy predicts fewer relapses
IVIG therapy appears to be the most effective for reducing relapses.
Conference Coverage
To prevent MS, should we target EBV?
Can a vaccine against EBV reduce MS incidence on a population level? Two experts debate.
Conference Coverage
Differential diagnosis in MS: What to watch for
‘Red flags’ suggest something other than MS.
Conference Coverage
CBT alone and with meds may decrease MS fatigue
“Clinicians should consider clinical characteristics and overall treatment goals when selecting fatigue interventions, to offer a more...
Feature
Health plans get very poor scores for access to autoimmune drugs
Three out of four insurance plans use policies that result in significant to severe restriction of access to medications for seven autoimmune...
Literature Review
Biosimilar equal to natalizumab for relapsing remitting MS
Biosim-NTZ is the first biosimilar monoclonal antibody therapy to be developed for MS.
Latest News
Poor sleep quality as a teen may up MS risk in adulthood
Individuals who slept less than 7 hours a night on average during adolescence were 40% more likely to develop MS later on.
30th Anniversary
Despite ongoing challenges, experts are optimistic about the future of MS therapy
To celebrate our 30th year in print, Neurology Reviews invited experts to look back on the trajectories of various neurology subspecialties. In...